Product image of Lacryvisc (Carbomer 974p) supplied by GNH India

Lacryvisc

Active Ingredient:
Carbomer 974p
Origin:
EU

Lacryvisc (Carbomer 974p)

Carbomer 974P, the active ingredient in Lacryvisc, is a viscosity agent presented as an ophthalmic solution for ocular use. It increases the lubricating film on the eye surface to relieve dryness and irritation in patients with ocular surface disorders.

GNH India supplies Lacryvisc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Alcon Healthcare S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacryvisc is an ocular viscosity agent used to manage conditions affecting the tear film and ocular surface.

  • Dry eye disease: provides long‑lasting lubrication to relieve dryness and irritation.
  • Contact lens discomfort: reduces friction and improves comfort during lens wear.
  • Post‑operative ocular irritation: protects the cornea and promotes healing after eye surgery.
  • Environmental eye strain: mitigates dryness caused by low humidity or wind exposure.

How It Works

  • Carbomer 974P is a high‑molecular‑weight polymer that swells upon hydration, forming a viscous gel on the ocular surface. This gel enhances tear film stability, creates a protective barrier, and prolongs the residence time of the lubricant, thereby reducing friction and alleviating surface dryness.

Side Effects

Lacryvisc may cause ocular reactions, most of which are mild and transient.

Common Side Effects

  • Transient blurred vision: temporary visual disturbance after instillation.
  • Mild ocular irritation: sensation of burning or stinging.
  • Tearing: increased tear production.
  • Redness of the conjunctiva: mild hyperemia.

Serious or Rare Side Effects

  • Allergic reaction: swelling, itching, or rash around the eye.
  • Severe eye inflammation: marked redness, pain, or swelling.
  • Corneal ulceration or vision loss: rare but requires immediate medical attention.

Precautions & Warnings

Before using Lacryvisc, consider the following safety measures.

  • Hypersensitivity: discontinue if signs of allergic reaction appear.
  • Pre‑existing eye infection: consult a clinician before application.
  • Contact lens wearers: remove lenses before instillation and re‑insert after a few minutes.
  • Use with caution in patients undergoing ocular surgery.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Lacryvisc may interact with other ophthalmic products; monitor for combined effects.

Major Interactions (Avoid)

  • Concurrent use with ophthalmic solutions containing preservatives that can increase irritation.
  • Simultaneous administration with topical antibiotics that may be diluted, reducing efficacy.

Moderate Interactions (Monitor Closely)

  • Use with other ocular lubricants may cause excess viscosity and blurred vision.
  • Combination with anti‑inflammatory eye drops may alter drug distribution on the surface.

Frequently Asked Questions

Lacryvisc is an ophthalmic viscosity agent designed to lubricate the ocular surface. It is commonly employed to relieve dryness, improve comfort for contact lens wearers, and protect the eye after surgical procedures.

Carbomer 974P is a polymer that absorbs water and forms a gel‑like layer on the eye. This layer increases tear film stability, reduces friction, and maintains moisture, thereby alleviating symptoms of dry eye and irritation.

The dosing regimen for Lacryvisc is determined by the prescribing clinician based on the patient’s condition and response. Typically, one to two drops are instilled in the affected eye(s) as needed.

Safety data for Lacryvisc in pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit profile before prescribing it to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lacryvisc uses Carbomer 974P, which creates a higher‑viscosity gel compared with many traditional aqueous eye drops. This can offer longer‑lasting relief but may cause transient blurred vision, whereas simpler drops may require more frequent application.

Store Lacryvisc at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct sunlight and moisture, and avoid freezing.

Lacryvisc is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops onto the conjunctival sac without touching the bottle tip to the eye.

Serious risks, though rare, include allergic reactions such as swelling or rash around the eye, severe inflammation, and, in extreme cases, corneal ulceration or vision loss. Any of these symptoms require immediate medical attention.

Individuals with known hypersensitivity to Carbomer 974P or any excipients in the formulation should avoid Lacryvisc. Patients with active ocular infections should consult a healthcare professional before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.